BAMCO Inc
IMMU

BAMCO Inc’s Immunomedics Inc IMMU Stock Holding History

BAMCO Inc’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,815
Closed -$242K – 374
2020
Q2 		$242K Buy
+6,815
New +$199K ﹤0.01% 299

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BAMCO Inc's IMMU Position: Q3 2020 in Review

BAMCO Inc sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 6,815 shares — an estimated $242K sold.

BAMCO Inc first reported a position in IMMU in Q2 2020 and held it in 1 quarter. The position peaked at $242K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • BAMCO Inc reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • BAMCO Inc sold 6,815 Immunomedics Inc shares in Q3 2020, an estimated $242K.
  • BAMCO Inc first reported a position in Immunomedics Inc in Q2 2020 and held it in 1 quarter.
  • BAMCO Inc's Immunomedics Inc position peaked at $242K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on BAMCO Inc's 13F filing for Q3 2020, filed 13 Nov 2020.